Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series.

Clinton G LauritsenSantiago MazueraRichard B LiptonSait Ashina

Published in: The journal of headache and pain (2016)

IV ketamine was safely administered in the hospital setting to patients with refractory chronic migraine. Treatment was associated with short term improvement in pain severity in 6 of 6 patients with refractory chronic migraine. Prospective placebo-controlled trials are needed to assess short term and long-term efficacy of IV ketamine in refractory chronic migraine.

Keyphrases

pain management
healthcare
chronic pain
randomized controlled trial
placebo controlled
drug induced
squamous cell carcinoma
clinical trial
high dose
spinal cord injury
double blind
study protocol
combination therapy
open label
smoking cessation
phase ii study
phase iii
locally advanced